Finoriq

Finoriq insights

ZeroStack Corp. (ZSTK) SEC Filings & Filing Highlights

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution. Review ZSTK SEC filings, filing highlights, and disclosure activity on Finoriq.

Company Snapshot

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.

Company
ZeroStack Corp. (ZSTK)
Ticker
ZSTK
Market Cap
$118.4M
Latest Price
$5.425
Industry
Other Pharmaceuticals

Open insider transactions

ZeroStack Corp. (ZSTK) Recent SEC Filing Highlights

Recent SEC filings, filing events, and disclosure highlights indexed for ZeroStack Corp. (ZSTK).

EventFormDate
On May 5, 2026, the independent members of the board of directors (the "Board") of ZeroStack Co...On May 5, 2026, the independent members of the board of directors (the "Board") of ZeroStack Corp. (the "Company") granted (i) 500,000 stoc...8-K5.022026-05-06
ZeroStack Corp.: Securities issuanceThe information under the headers "Share Exchange Agreement" in Item 1.01 of this Current Report on Form 8-K is incorporated herein by refe...8-K3.022026-03-31
Blocker Securities Contribution Agreements and Blocker Stockholders' AgreementBlocker Securities Contribution Agreements and Blocker Stockholders' Agreement8-K1.012026-03-31
ZeroStack Corp.: Corporate updateUpon opening of the markets on January 29, 2026, the Company's common shares (the "Common Shares"), which trade on the Nasdaq Capital Marke...8-K8.012026-01-29
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year8-K5.032026-01-29

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.